Alpha Signal Monitor - Daily Market Briefing | April 22, 2026
Daily Market Research Report
April 22, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional views on Gold ETFs (GLD, IAU, BAR) — as of April 22, 2026
Trading Idea: Buy (overweight exposure to physically backed gold ETFs such as GLD, IAU, BAR) Rationale (TL;DR): Most top-tier houses (Goldman Sachs, J.P. Morgan, UBS, Bank of America, HSBC, Morgan Stanley) retain bullish 2026 targets in the $4,400–$6,300/oz range, while the main dissent (Citi) is cautious into late‑2026; on balance, expected central‑bank and private‑sector demand, softer real rates, and a weaker USD support adding or buying dips in gold ETFs into year‑end 2026. (bloomberg.com)
Gold’s current cycle is being driven by persistent official‑sector buying, renewed ETF inflows/private diversification, and an expected Fed easing path/softer USD. Several banks explicitly cite central‑bank purchases and investor reallocation as the pillars of their 2026 targets. (ubs.com)
Key Drivers - Central‑bank demand expected to remain elevated through 2026, underpinning prices. (ubs.com) - Return of ETF/investor inflows and private‑sector diversification into bullion. (bloomberg.com) - Lower US real rates and a weaker USD supportive for non‑yielding gold. (morganstanley.com) - Ongoing geopolitical/policy uncertainty sustaining the ‘hedge’ bid. (investing.com) - Constrained new mine supply vs. investment‑led demand. (thestreet.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Overweight/Buy | $5,400/oz by Dec‑2026 | GS raised its Dec‑2026 target to $5,400, citing growing private‑sector diversification on top of strong central‑bank and ETF demand. | 2026-01-22 | https://www.bloomberg.com/news/articles/2026-01-22/goldman-sachs-raises-year-end-gold-forecast-to-5-400-an-ounce |
| Morgan Stanley | Overweight/Buy | ~$4,400/oz by end‑2026 | MS expects the rally to continue; revised 2026 forecast to ~$4,400 on central‑bank reserve shifts, ETF inflows, prospective Fed cuts, and weaker USD; flags demand‑destruction risk at very high prices. | 2025-10-22 | https://www.morganstanley.com/insights/articles/gold-price-forecast-rally-into-2026 |
| JP Morgan | Overweight/Buy | $6,300/oz by end‑2026 (long‑term anchor to ~$4,500) | JPM now forecasts enough central‑bank and investor demand to push gold to $6,300 by end‑2026; also lifted long‑term price anchor to ~$4,500. | 2026-02-25 | https://www.investing.com/news/commodities-news/jp-morgan-sees-yearend-2026-gold-price-at-6300-per-ounce-4523320?utm_source=openai |
| Bank of America | Overweight/Buy | $5,000/oz by 2026 (avg ~ $4,400) | BofA raised its 2026 outlook to $5,000, arguing supportive macro drivers remain in place (policy mix, deficits) despite potential near‑term volatility. | 2025-10-13 | https://www.investing.com/news/economy-news/factboxbofa-hikes-gold-price-forecast-to-5000oz-for-2026-4283688?utm_source=openai |
| Citigroup | Neutral/Hold to Underweight/Sell (cautious) | Baseline downside risk toward ~$3,700 by end‑2026 (earlier notes flagged sub‑$3,000 scenarios) | Citi turned cautious into late‑2026, seeing scope for a retracement as risk premia fade and growth stabilizes; January press cited ~$3,700 by year‑end 2026 after a December recommendation cut. | 2026-01-04 | https://cincodias.elpais.com/mercados-financieros/2026-01-04/que-esperar-del-oro-y-la-plata-en-2026-tras-un-ano-de-maximos-historicos.html |
| UBS | Overweight/Buy (Attractive; remain long) | $6,200/oz for Mar–Sep 2026; ~$5,900 by Dec‑2026 (upside $7,200; downside $4,600) | UBS CIO raised targets on stronger investment demand and persistent central‑bank buying; maintains long in global allocation. | 2026-01-29 | https://www.ubs.com/global/en/wealthmanagement/insights/chief-investment-office/house-view/daily/2026/latest-30012026/jcr_content/root/contentarea/mainpar/toplevelgrid_copy_co/col_1/textimage_copy_copy.2049295996.file/dGV4dD0vY29udGVudC9kYW0vYXNzZXRzL3dtL2dsb2JhbC9jaW8vaG91c2Utdmlldy9kb2N1bWVudC9nb2xkLWVuLTE2NTM3ODQucGRm/gold-en-1653784.pdf |
| HSBC | Overweight/Buy (with peak risk in 1H26) | Peak risk up to ~$5,000 in 1H‑2026; 2026 average ~ $4,600/oz | HSBC sees the bull wave potentially pushing gold to $5,000 in 1H‑2026, with an average around $4,600 supported by official‑sector and ETF demand. | 2025-10-17 | https://www.mining.com/web/hsbc-expects-golds-bull-wave-to-hit-5000-in-2026/?utm_source=openai |
| Deutsche Bank | Neutral/Positive (raised baseline) | $4,450/oz in 2026 (select commentary flags upside scenarios) | DB lifted its 2026 forecast to $4,450 on stabilizing investor flows and persistent central‑bank demand; some later media noted upside toward $6,000 under weaker‑USD scenarios. | 2025-11-26 | https://www.investing.com/news/stock-market-news/deutsche-bank-raises-2026-gold-price-forecast-to-4450oz-4379092?utm_source=openai |
Risk Considerations - Stronger‑than‑expected US growth/real yields or USD rebound could pressure gold. (morganstanley.com) - Demand destruction at high prices (jewelry/retail), slowing official purchases. (morganstanley.com) - Positioning washouts/volatility leading to sharp drawdowns before year‑end 2026. (investing.com) - Bearish or cautious house views (e.g., Citi sees downside into late‑2026) materialize. (cincodias.elpais.com)
Maintain Buy on physically backed ETFs (GLD/IAU/BAR). Implementation: accumulate on pullbacks; reassess sizing if US real yields or USD trend higher for several months or if official‑sector demand meaningfully slows. Base case leans to new highs into late‑2026 with elevated volatility; risk‑manage via staggered entries or options overlays where appropriate. (bloomberg.com)
Stock Ratings — Mega‑Cap Tech: Street Targets and Ratings (as of April 22, 2026)
Compiled latest publicly reported target prices and ratings from Goldman Sachs (GS/高盛), Morgan Stanley (MS/大摩), JPMorgan (JPM/小摩), Bank of America (BAC/美银), Citigroup (C/花旗), and Wells Fargo (WFC/富国银行) for the requested tickers. Original research is often paywalled; where available, we cite reliable news wires or coverage that report the institutions’ views. Ratings like Overweight/Outperform are treated as Buy equivalents for the consensus.
AAPL - Apple Inc.
All six covered: latest range $275–$325; most recent change was BAC raising PT to $325 (Apr 14, 2026). Consensus skews Buy with ~$308 target.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $320 | 2026-01-20 | Reiterated Buy; maintained $320 PT. | https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-amid-recent-decline-93CH-4454913 |
| Morgan Stanley | Overweight | $315 | 2026-01-26 | Reiterated Overweight at $315 into earnings. | https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-apple-stock-at-315-93CH-4464224 |
| JP Morgan | Overweight | $315 | 2026-01-26 | Raised PT to $315 from $305; kept Overweight. | https://www.investing.com/news/analyst-ratings/apple-stock-price-target-raised-to-315-from-305-at-jpmorgan-93CH-4465277 |
| Bank of America | Buy | $325 | 2026-04-14 | Raised PT to $325 from $320; kept Buy. | https://www.investing.com/news/analyst-ratings/bofa-raises-apple-stock-price-target-to-325-on-iphone-strength-93CH-4612112 |
| Citigroup | Buy | $275 | 2025-03-31 | Maintained Buy, $275 PT. | https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-275-target-93CH-3958803 |
| Wells Fargo | Overweight | $300 | 2025-12-29 | Reiterated Overweight, $300 PT, citing China share gains. | https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681 |
Consensus View - Rating: Buy, Target Price: $308.33 - Uniformly positive skew (Buy/Overweight) with average of six listed targets ≈ $308.
MSFT - Microsoft Corp.
Coverage broad and positive; MS at $650 (Jan 14, 2026) is the high among the six; WFC trimmed to $665 on Jan 8, 2026; consensus ≈ $555.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $500 | 2025-01-30 | Reiterated Buy and $500 PT after FY25 Q2. | https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-microsoft-stock-buy-rating-500-target-93CH-3839297 |
| Morgan Stanley | Overweight | $650 | 2026-01-14 | Reiterated Overweight, $650 PT post CIO survey. | https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158 |
| JP Morgan | Overweight | $475 | 2025-05-01 | Raised PT to $475; kept Overweight. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871 |
| Bank of America | Buy | $500 | 2026-03-24 | Reiterated Buy with $500 PT. | https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-earns-buy-rating-from-bank-of-america-2026-03-24/ |
| Citigroup | Buy | $540 | 2025-05-15 | Raised PT to $540; maintained Buy. | https://www.investing.com/news/analyst-ratings/citi-raises-microsoft-stock-price-target-to-540-from-480-4047152 |
| Wells Fargo | Overweight | $665 | 2026-01-08 | Maintained Overweight; trimmed PT to $665 from $700. | https://www.gurufocus.com/news/4102202/wells-fargo-adjusts-price-target-for-microsoft-msft-to-665-msft-stock-news |
Consensus View - Rating: Buy, Target Price: $555.00 - Average of six listed targets (Buy/Overweight skew) ≈ $555.
GOOGL - Alphabet Inc.
Targets vary widely with 2H25 updates and 1Q26 resets; most recent notable were JPM to $300 (Oct 27, 2025) and WFC to $387 with Overweight (Mar 2026). Consensus math from entries ≈ $268 and Buy-skew.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $234 | - | Reiterated Buy; $234 PT following search remedies context (7 months prior). | https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041 |
| Morgan Stanley | Overweight | $205 | - | Raised PT to $205; kept Overweight (9 months prior). | https://it.investing.com/news/analyst-ratings/morgan-stanley-alza-il-target-di-prezzo-di-alphabet-a-205-da-185-93CH-2909910 |
| JP Morgan | Overweight | $300 | 2025-10-27 | Raised PT to $300 from $260 on AI strength. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660 |
| Bank of America | Buy | $280 | 2025-10-20 | Raised PT to $280; maintained Buy ahead of Oct 29 earnings. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307 |
| Citigroup | Buy | $200 | - | Maintained Buy, $200 PT (≈ 11 months prior). | https://www.investing.com/news/analyst-ratings/citi-maintains-buy-rating-and-200-target-on-alphabet-stock-4056278 |
| Wells Fargo | Overweight | $387 | - | Upgraded to Overweight; raised PT to $387 (≈ last month). | https://www.investing.com/news/analyst-ratings/wells-fargo-mejora-la-calificacion-de-las-acciones-de-alphabet-por-expansion-de-capacidad-de-computo-93CH-3526425 |
Consensus View - Rating: Buy, Target Price: $267.67 - Average of six listed targets ≈ $268; majority Buy/Overweight despite dispersion.
AMZN - Amazon.com Inc.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
NVDA - NVIDIA Corp.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
META - Meta Platforms Inc.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
TSLA - Tesla Inc.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
AVGO - AVGO Corp.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
TSM - TSM Corp.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Highlights
- AAPL: BAC raised PT to $325 and kept Buy on Apr 14, 2026; MS and JPM each at $315 Overweight; GS reiterated Buy at $320 in Jan 2026.
- MSFT: MS reiterated Overweight with $650 PT (Jan 14, 2026); WFC trimmed to $665 on Jan 8, 2026; BAC reiterated Buy at $500 on Mar 24, 2026.
- GOOGL: JPM raised to $300 (Oct 27, 2025); BAC raised to $280 (Oct 20, 2025); WFC upgraded to Overweight with $387 PT (Mar 2026).
- Consensus snapshots: AAPL ≈ $308 (Buy); MSFT ≈ $555 (Buy); GOOGL ≈ $268 (Buy).
Would you like me to continue filling AMZN, NVDA, META, TSLA, AVGO, and TSM next, or prioritize any names/banks first? If you have access to licensed terminals (Bloomberg/FactSet/Refinitiv), I can cross‑verify and replace any entries with primary-source excerpts to increase precision on dates and wording.
IPO Calendar
Timeframe: April 22, 2026 to May 22, 2026 — US equity markets
Set to kick off with Yesway’s debut today (April 22), the next month’s US IPO slate features a mix of consumer, real assets and energy/industrial names: a convenience-store operator (Yesway), a healthcare REIT (National Healthcare Properties), an advanced nuclear reactor developer (X‑Energy), and a defense/critical‑materials manufacturer (The Elmet Group). Recent pricings in defense/industrial (Madison Air, Arxis) and aero/ISR (AEVEX) underscore investor appetite for cash‑flowing, hard‑asset businesses amid elevated geopolitical risk, while biotech also showed signs of life with a sizable obesity‑drug IPO last week. Calendar visibility beyond late April is still fluid and may shift with market volatility. (nasdaq.com)
Yesway, Inc. (YSWY)
- Expected listing date: 2026-04-22
- Price range: $20 per share (priced Apr 21, 2026; filed range $20–$23)
- Shares offered: 14,000,000 primary shares; 30‑day option for 2,100,000 additional shares
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Morgan Stanley (lead bookrunner), J.P. Morgan (active bookrunner), Goldman Sachs (active bookrunner), Barclays, BMO Capital Markets, KeyBanc Capital Markets, Guggenheim Securities, Raymond James
- Business summary: Large US convenience-store operator of the Yesway and Allsup’s banners across the Midwest and Southwest; proceeds support balance sheet and growth.
- Notes: Trading expected to begin Wednesday, April 22, 2026. Final sizing and greenshoe subject to customary closing conditions. Allocation and aftermarket performance may be sensitive to fuel margins and broader consumer sentiment.
- Sources: https://www.nasdaq.com/press-release/yesway-announces-launch-initial-public-offering-2026-04-13, https://www.investing.com/news/stock-market-news/convenience-store-owner-yesway-raises-280-million-in-us-ipo-4628027, https://www.stocktitan.net/news/YSWY/yesway-announces-pricing-of-initial-public-9buxm2h5cq8e.html
National Healthcare Properties, Inc. (REIT) (NHP)
- Expected listing date: 2026-04-22
- Price range: $13–$16 (filed)
- Shares offered: 38,500,000 primary shares; 5,775,000 share over‑allotment option
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Wells Fargo Securities (lead bookrunner), Morgan Stanley (lead bookrunner), BMO Capital Markets (lead bookrunner), Goldman Sachs, RBC Capital Markets, Baird, Capital One Securities, Citizens Capital Markets, Fifth Third Securities, Huntington Capital Markets, KeyBanc Capital Markets, Crédit Agricole CIB (co‑manager), Synovus (co‑manager)
- Business summary: Self‑managed REIT focused on senior housing operating properties and outpatient medical facilities across the US; proceeds earmarked for debt reduction and growth investments.
- Notes: Registration statement not yet effective; timing subject to SEC effectiveness and market conditions. Multiple bookrunners reflect broad institutional distribution. Some calendars show the deal targeted for the week of April 22, 2026.
- Sources: https://investors.nhpreit.com/Investors/investor-news/news-details/2026/National-Healthcare-Properties-Announces-Launch-of-Public-Offering/default.aspx, https://www.ipox.com/ipo-calendar/national-healthcare-properties, https://www.ifre.com/equities/2411788/national-healthcare-properties-targets-us616m-ipo
X‑Energy, Inc. (XE)
- Expected listing date: 2026-04-24
- Price range: $16–$19 (filed)
- Shares offered: 42,857,143 primary shares (plus standard 30‑day underwriters’ option)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan, Morgan Stanley, (additional managers per prospectus)
- Business summary: Advanced nuclear company developing the Xe‑100 high‑temperature gas‑cooled small modular reactor and TRISO‑based fuel; capital supports first deployments and fuel manufacturing scale‑up.
- Notes: Company launched roadshow April 15, 2026; some sources indicate up to ~$750–$814 million in gross proceeds depending on pricing and option exercise. Expected to price/list in the week of April 22–26, 2026, subject to market conditions.
- Sources: https://x-energy.com/news/x-energy-announces-launch-of-its-initial-public-offering/, https://www.renaissancecapital.com/IPO-Center/News/118337/Small-modular-reactor-developer-X-Energy-sets-terms-for-%24750-million-IPO, https://www.ipox.com/ipo-calendar/w62kka4zvb9rwk0ni177pu6aei1xjt, https://www.sec.gov/Archives/edgar/data/2088896/000110465926043799/tm2527015-17_s1a.htm
The Elmet Group Co. (ELMT)
- Expected listing date: 2026-04-23
- Price range: $12–$14 (filed)
- Shares offered: 7,692,307 primary shares; 30‑day option for ~1,153,846 additional shares
- Exchange: Nasdaq Capital Market
- Lead underwriters: Cantor (lead bookrunner), Needham & Company, Canaccord Genuity, Roth Capital Partners
- Business summary: US manufacturer of precision components and engineered systems using refractory metals (tungsten, molybdenum, niobium) and high‑power microwave technologies for aerospace/defense, semiconductors, medical and energy end‑markets.
- Notes: Launch announced April 14, 2026; listing targeted the following week. Final timing and size remain subject to effectiveness and market conditions.
- Sources: https://theelmetgroup.com/the-elmet-group-announces-launch-of-initial-public-offering/, https://www.globenewswire.com/news-release/2026/04/14/3273164/0/en/The-Elmet-Group-Co-Announces-Launch-of-Initial-Public-Offering.html, https://www.tipranks.com/calendars/ipo
Riku Dining Group Ltd. (RIKU)
- Expected listing date: 2026-05-05
- Price range: $4–$6 (filed)
- Shares offered: 5,000,000 primary shares (upsized from 2,250,000)
- Exchange: Nasdaq Capital Market
- Lead underwriters: Eddid Securities USA Inc.
- Business summary: Operator of Japanese‑themed restaurant brands with company‑owned and franchised locations in Canada and Hong Kong; proceeds to fund expansion and working capital.
- Notes: Small‑cap, cross‑border issuer; timing and sizing are tentative and subject to change. Calendars point to early May, but effectiveness and exchange approval will determine the final date.
- Sources: https://www.renaissancecapital.com/IPO-Center/News/117701/Japanese-style-restaurant-group-Riku-Dining-Group-sets-terms-for-%2425-millio, https://longbridge.com/en/news/279325603, https://www.tipranks.com/calendars/ipo
IPO calendars change quickly. Dates, price ranges, share counts, and even whether a deal prices at all can shift based on SEC effectiveness, investor demand, and market conditions. Treat all ‘expected’ dates as tentative until the issuer or exchange confirms. Key schedule context and term confirmations were drawn from issuer press releases, exchange/IR pages, and Renaissance Capital’s week‑ahead notes; third‑party calendar snapshots (e.g., IPOX, TipRanks, IFR) were used only to triangulate dates and may update intra‑week. (nasdaq.com)
Sources
- Stock Ratings: https://it.investing.com/news/analyst-ratings/morgan-stanley-alza-il-target-di-prezzo-di-alphabet-a-205-da-185-93CH-2909910, https://www.gurufocus.com/news/4102202/wells-fargo-adjusts-price-target-for-microsoft-msft-to-665-msft-stock-news, https://www.investing.com/news/analyst-ratings/apple-stock-price-target-raised-to-315-from-305-at-jpmorgan-93CH-4465277, https://www.investing.com/news/analyst-ratings/bofa-raises-apple-stock-price-target-to-325-on-iphone-strength-93CH-4612112, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307, https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-275-target-93CH-3958803, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-rating-and-200-target-on-alphabet-stock-4056278, https://www.investing.com/news/analyst-ratings/citi-raises-microsoft-stock-price-target-to-540-from-480-4047152, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-microsoft-stock-buy-rating-500-target-93CH-3839297, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-amid-recent-decline-93CH-4454913, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-apple-stock-at-315-93CH-4464224, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158, https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681, https://www.investing.com/news/analyst-ratings/wells-fargo-mejora-la-calificacion-de-las-acciones-de-alphabet-por-expansion-de-capacidad-de-computo-93CH-3526425, https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-earns-buy-rating-from-bank-of-america-2026-03-24/
- IPO Calendar: https://investors.nhpreit.com/Investors/investor-news/news-details/2026/National-Healthcare-Properties-Announces-Launch-of-Public-Offering/default.aspx, https://longbridge.com/en/news/279325603, https://theelmetgroup.com/the-elmet-group-announces-launch-of-initial-public-offering/, https://www.globenewswire.com/news-release/2026/04/14/3273164/0/en/The-Elmet-Group-Co-Announces-Launch-of-Initial-Public-Offering.html, https://www.ifre.com/equities/2411788/national-healthcare-properties-targets-us616m-ipo, https://www.investing.com/news/stock-market-news/convenience-store-owner-yesway-raises-280-million-in-us-ipo-4628027, https://www.ipox.com/ipo-calendar/national-healthcare-properties, https://www.ipox.com/ipo-calendar/w62kka4zvb9rwk0ni177pu6aei1xjt, https://www.nasdaq.com/press-release/yesway-announces-launch-initial-public-offering-2026-04-13, https://www.renaissancecapital.com/IPO-Center/News/117701/Japanese-style-restaurant-group-Riku-Dining-Group-sets-terms-for-%2425-millio, https://www.renaissancecapital.com/IPO-Center/News/118337/Small-modular-reactor-developer-X-Energy-sets-terms-for-%24750-million-IPO, https://www.sec.gov/Archives/edgar/data/2088896/000110465926043799/tm2527015-17_s1a.htm, https://www.stocktitan.net/news/YSWY/yesway-announces-pricing-of-initial-public-9buxm2h5cq8e.html, https://www.tipranks.com/calendars/ipo, https://x-energy.com/news/x-energy-announces-launch-of-its-initial-public-offering/
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-04-22 at 11:34 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI